ConductScience.org, home

Paper24367641

ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.

Moelans CB and 4 others. PLoS One, 2013. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous. Papers, record 24367641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24367641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
PubMed
Journal
PLoS One
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2023-11-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moelans CBCathy B
2Holst FFrederik
3Hellwinkel OOlaf
4Simon RRonald
5van Diest PJPaul J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Estrogen Receptor alphaMajor topic
Gene AmplificationMajor topic
In Situ Hybridization, FluorescenceMajor topic
RibonucleasesMajor topic
Artifacts
DNA Copy Number Variations
Humans
Laser Capture Microdissection
Tissue Array Analysis

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117070983Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.Eur Urol2007https://conductscience.org/library/papers/17070983PubMed
214077492THE DESTABILIZING EFFECT OF RIBONUCLEASE ON THE HELICAL DNA STRUCTURE.Proc Natl Acad Sci U S A1963https://conductscience.org/library/papers/14077492PubMed
3993211DNA "melting" proteins. I. Effects of bovine pancreatic ribonuclease binding on the conformation and stability of DNA.J Biol Chem1976https://conductscience.org/library/papers/993211PubMed
47585609ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer.Cancer Res1995https://conductscience.org/library/papers/7585609PubMed
58557734Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains.J Cell Biol1995https://conductscience.org/library/papers/8557734PubMed
617417639Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.Nat Genet2007https://conductscience.org/library/papers/17417639PubMed
719052028An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology.J Clin Pathol2009https://conductscience.org/library/papers/19052028PubMed
816756668Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia.BMC Genomics2006https://conductscience.org/library/papers/16756668PubMed
916288303HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.Br J Cancer2005https://conductscience.org/library/papers/16288303PubMed
1012360235Human cytogenetics: 46 chromosomes, 46 years and counting.Nat Rev Genet2002https://conductscience.org/library/papers/12360235PubMed
1120826716EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.Ann Oncol2011https://conductscience.org/library/papers/20826716PubMed
1218607067MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data.Cell Oncol2008https://conductscience.org/library/papers/18607067PubMed
1320442492Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value.Cell Oncol2010https://conductscience.org/library/papers/20442492PubMed
1422942022Statistical challenges associated with detecting copy number variations with next-generation sequencing.Bioinformatics2012https://conductscience.org/library/papers/22942022PubMed
1521986093Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.Ann Oncol2012https://conductscience.org/library/papers/21986093PubMed
1616791841MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.Hum Mutat2006https://conductscience.org/library/papers/16791841PubMed
1716051952Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.J Clin Oncol2005https://conductscience.org/library/papers/16051952PubMed
188608736Reutilization of previously hybridized slides for fluorescence in situ hybridization.Cytometry1995https://conductscience.org/library/papers/8608736PubMed
1919320640Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.Cancer Sci2009https://conductscience.org/library/papers/19320640PubMed
2022137795Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.Cancer Cell2011https://conductscience.org/library/papers/22137795PubMed

See all 39 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
40244377Molecular Mechanisms and Therapeutic Strategies to Overcome Resistance to Endocrine Therapy and CDK4/6 Inhibitors in Advanced ER+/HER2- Breast Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40244377PubMed
38930141Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.J Clin Med2024https://conductscience.org/library/papers/38930141PubMed
35179206Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.Br J Surg2022https://conductscience.org/library/papers/35179206PubMed
33229445Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination.Gut2021https://conductscience.org/library/papers/33229445PubMed
30995757Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients.Int J Mol Sci2019https://conductscience.org/library/papers/30995757PubMed
30382472Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals.Breast Cancer Res Treat2019https://conductscience.org/library/papers/30382472PubMed
29736566The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.Horm Cancer2018https://conductscience.org/library/papers/29736566PubMed
27761212Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?Iran J Cancer Prev2016https://conductscience.org/library/papers/27761212PubMed
27160768Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.Sci Rep2016https://conductscience.org/library/papers/27160768PubMed
27081639Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.World J Clin Oncol2016https://conductscience.org/library/papers/27081639PubMed
25907219Mechanisms of aromatase inhibitor resistance.Nat Rev Cancer2015https://conductscience.org/library/papers/25907219PubMed
25838462Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.J Natl Cancer Inst2015https://conductscience.org/library/papers/25838462PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24367641

GET https://conductscience.org/api/papers/v1/24367641/references?page=2